These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15381522)

  • 1. Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor.
    Gerstein HC
    Ann Intern Med; 2004 Sep; 141(6):475-6. PubMed ID: 15381522
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for patients. The relationship between blood sugar control and cardiovascular disease in patients with diabetes.
    Ann Intern Med; 2004 Sep; 141(6):I21. PubMed ID: 15381537
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.
    Selvin E; Marinopoulos S; Berkenblit G; Rami T; Brancati FL; Powe NR; Golden SH
    Ann Intern Med; 2004 Sep; 141(6):421-31. PubMed ID: 15381515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
    Maahs DM
    Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. The relationship between blood sugar levels and cardiovascular disease.
    Ann Intern Med; 2004 Sep; 141(6):I12. PubMed ID: 15381536
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of nurse-led diabetes self-management education on glycosylated hemoglobin and cardiovascular risk factors: a meta-analysis.
    Tshiananga JK; Kocher S; Weber C; Erny-Albrecht K; Berndt K; Neeser K
    Diabetes Educ; 2012; 38(1):108-23. PubMed ID: 22116473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological variation of cardiovascular risk factors in patients with diabetes.
    Dawson AJ; Sathyapalan T; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1172-80. PubMed ID: 23413821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control and CAD risk: a heretical thought.
    Orchard TJ
    Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
    [No Abstract]   [Full Text] [Related]  

  • 10. Summaries for patients. Chronic health problems seem to influence the relationship of blood sugar control and cardiovascular events in patients with type 2 diabetes.
    Ann Intern Med; 2009 Dec; 151(12):I54. PubMed ID: 20008745
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of glycemia management in the prevention of cardiovascular disease--starting over?
    Nathan DM
    Ann Intern Med; 2009 Dec; 151(12):888-9. PubMed ID: 20008764
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycemic variability in the development of cardiovascular complications in diabetes.
    Nusca A; Tuccinardi D; Albano M; Cavallaro C; Ricottini E; Manfrini S; Pozzilli P; Di Sciascio G
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3047. PubMed ID: 30028067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
    Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
    Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
    Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
    Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How low to go? Blood glucose and heart health.
    Diabetes Forecast; 2008 Apr; 61(4):21. PubMed ID: 18478637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Near-norm blood sugar regulation in diabetes. Myocardial infarct rate halved].
    MMW Fortschr Med; 2005 Sep; 147(35-36):4-5. PubMed ID: 16180560
    [No Abstract]   [Full Text] [Related]  

  • 17. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients.
    Briguori C; Condorelli G; Airoldi F; Mikhail GW; Ricciardelli B; Colombo A
    Heart; 2004 Dec; 90(12):1481-2. PubMed ID: 15547037
    [No Abstract]   [Full Text] [Related]  

  • 20. The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice.
    Reutens AT; Hutchinson R; Van Binh T; Cockram C; Deerochanawong C; Ho LT; Ji L; Khalid BA; Kong AP; Lim-Abrahan MA; Tan CE; Tjokroprawiro A; Yoon KH; Zimmet PZ; Shaw JE
    Diabetes Res Clin Pract; 2012 Oct; 98(1):38-45. PubMed ID: 22784926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.